Final answer:
The most reliable oral argument on the subject of the new drug is likely to come from the independent researcher who evaluated the drug based on scientific evidence. The inventor of the drug who conducted clinical trials can also provide reliable information, but potential conflicts of interest should be considered. The patient's argument may be subjective and based on personal experiences.
Step-by-step explanation:
The most reliable oral argument on the subject of the new drug at the conference on infectious diseases is likely to come from the independent researcher who evaluated the new drug and its effects on the target disease. An independent researcher is an unbiased source and their evaluation of the drug will be based on scientific evidence and rigorous testing. They would have thoroughly analyzed the drug's efficacy, safety, and potential side effects.
On the other hand, the inventor of the drug who ran several clinical trials before seeking a patent for the formula could also provide reliable information. However, there may be a potential conflict of interest as the inventor may have a stake in the success of the drug. So while their insights are valuable, they should be considered alongside other sources.
The patient who suffers from the target disease and has been helped by experimental use of the drug can provide a valuable perspective, but their argument may be subjective and based on personal experiences rather than scientific evidence.
Learn more about reliable sources for oral argument on the subject of a new drug